Reaction Details |
| Report a problem with these data |
Target | POU domain, class 2, transcription factor 2 |
---|
Ligand | BDBM448200 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Inhibition Assay |
---|
IC50 | 358±n/a nM |
---|
Citation | Bacon, EM; Cai, ZR; Chen, X; Cottell, JJ; Desai, MC; Ji, M; Jin, H; Lazerwith, SE; Mish, MR; Morganelli, PA; Pyun, H; Taylor, JG; Trejo Martin, TA Substituted 3,4,5,6,8,10,14,14a-octahydro-2h-2,6-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazocines and methods for treating viral infections US Patent US10689399 Publication Date 6/23/2020 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
POU domain, class 2, transcription factor 2 |
---|
Name: | POU domain, class 2, transcription factor 2 |
Synonyms: | Lymphoid-restricted immunoglobulin octamer-binding protein NF-A2 | OCT2 | OCT2 | OTF-2 | OTF2 | Oct-2 | Octamer-binding protein 2 | Octamer-binding transcription factor 2 | Octamer-binding transcription factor 2 (OCT2) | PO2F2_HUMAN | POU domain, class 2, transcription factor 2 | POU2F2 |
Type: | PROTEIN |
Mol. Mass.: | 51217.88 |
Organism: | Homo sapiens (Human) |
Description: | ChEMBL_109671 |
Residue: | 479 |
Sequence: | MVHSSMGAPEIRMSKPLEAEKQGLDSPSEHTDTERNGPDTNHQNPQNKTSPFSVSPTGPS
TKIKAEDPSGDSAPAAPLPPQPAQPHLPQAQLMLTGSQLAGDIQQLLQLQQLVLVPGHHL
QPPAQFLLPQAQQSQPGLLPTPNLFQLPQQTQGALLTSQPRAGLPTQAVTRPTLPDPHLS
HPQPPKCLEPPSHPEEPSDLEELEQFARTFKQRRIKLGFTQGDVGLAMGKLYGNDFSQTT
ISRFEALNLSFKNMCKLKPLLEKWLNDAETMSVDSSLPSPNQLSSPSLGFDGLPGRRRKK
RTSIETNVRFALEKSFLANQKPTSEEILLIAEQLHMEKEVIRVWFCNRRQKEKRINPCSA
APMLPSPGKPASYSPHMVTPQGGAGTLPLSQASSSLSTTVTTLSSAVGTLHPSRTAGGGG
GGGGAAPPLNSIPSVTPPPPATTNSTNPSPQGSHSAIGLSGLNPSTGPGLWWNPAPYQP
|
|
|
BDBM448200 |
---|
n/a |
---|
Name | BDBM448200 |
Synonyms: | US10689399, Compound 39 |
Type | Small organic molecule |
Emp. Form. | C22H21F2N3O5 |
Mol. Mass. | 445.416 |
SMILES | C[C@H]1C[C@@H]2C[C@H]1O[C@H]1Cn3cc(C(=O)NCc4ccc(F)cc4F)c(=O)c(O)c3C(=O)N21 |THB:29:31:1.2:4,0:1:7.6.31:4,8:7:1.2:4| |
Structure |
|